✦ LIBER ✦

Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients

✍ Scribed by George Dranitsaris, Eleftheria Hatzimichael

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Superiority of denosumab to zoledronic a

✍ Allan Lipton; Karim Fizazi; Alison T. Stopeck; David H. Henry; Janet E. Brown; D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 612 KB

Re: Superiority of denosumab to zoledron

✍ Araki, Kazuhiro; Ito, Yoshinori; Takahashi, Shunji 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Cost-effectiveness of denosumab vs zoled

✍ Stopeck, Alison; Rader, Michael; Henry, David; Danese, Mark; Halperin, Marc; Con 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 264 KB

Economic Evaluation Of Denosumab Versus

✍ Arocho, R.; Rivera Hurtado, R.; Carlos, F. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

PCN116 Cost-Effectiveness of Denosumab V

✍ Lothgren, M.; Bracco, A.; Lucius, B.; Northridge, K.; Halperin, M.; Macarios, D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN132 MODELING THE LIFETIME EFFECTIVENE

✍ M.D. Danese; A. Bracco; D. Macarios; K. Chung; A. Barlev; M. Halperin; M. Lothgr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB